US Broker Ratings

UroGen Pharma Ltd. (URGN) Stock Analysis: A Promising Biotech with Strong Buy Ratings and Nearly 20% Upside Potential

UroGen Pharma Ltd. (NASDAQ: URGN), a biotechnology company specializing in innovative therapies for urothelial and specialty cancers, is making headlines with its impressive stock performance and..

ClearPoint Neuro Inc. (CLPT) Stock Analysis: Exploring a Potential 100% Upside in the Healthcare Sector

ClearPoint Neuro Inc. (NASDAQ: CLPT), a dynamic player in the healthcare sector, is capturing investor interest with its focus on innovative medical devices for minimally invasive..

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: A Deep Dive into Its 63.69% Potential Upside

Entrada Therapeutics, Inc. (NASDAQ: TRDA), a promising player in the biotechnology sector, is making waves with its innovative approach to developing new classes of medicines targeting..

TruBridge, Inc. (TBRG) Stock Analysis: Healthcare Innovator with a Compelling Forward P/E of 9.84

TruBridge, Inc. (NASDAQ: TBRG) stands as a robust player in the healthcare sector, specifically within the Health Information Services industry. Headquartered in Mobile, Alabama, the company..

Pacific Biosciences of California (PACB) Stock Analysis: Navigating the Healthcare Innovator’s Path Amidst Market Challenges

Pacific Biosciences of California, Inc. (NASDAQ: PACB), a prominent player in the healthcare sector, continues to capture investor attention with its innovative sequencing solutions despite facing..

Nano-X Imaging Ltd (NNOX) Stock Analysis: Exploring a 79% Upside in the Medical Device Sector

Nano-X Imaging Ltd (NNOX), an innovative player in the healthcare sector, particularly in the medical devices industry, is garnering attention from investors with its ambitious mission..

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: Unpacking the 422% Potential Upside with Strong Analyst Support

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT), a promising player in the biotechnology sector, is drawing attention with its significant potential upside and a robust pipeline of..

Candel Therapeutics (CADL) Stock Analysis: Exploring a 303% Potential Upside in Cancer Immunotherapy

Candel Therapeutics, Inc. (NASDAQ: CADL) is making waves in the biotechnology sector with its promising pipeline of cancer immunotherapies. As a clinical-stage biopharmaceutical company, Candel is..

XOMA Royalty Corporation (XOMA) Stock Analysis: Biotech’s Hidden Gem with 118.85% Potential Upside

XOMA Royalty Corporation (XOMA), a key player in the biotechnology sector, is attracting significant attention from investors due to its unique business model and substantial growth..

Benitec Biopharma Inc. (BNTC) Stock Analysis: Exploring a Potential 98% Upside in the Biotech Space

For investors with an eye on high-potential opportunities in the healthcare sector, Benitec Biopharma Inc. (NASDAQ: BNTC) presents an intriguing prospect. As a clinical-stage biotechnology company,..

Anbio Biotechnology (NNNN) Investor Outlook: Navigating Revenue Declines and Market Volatility

Anbio Biotechnology (NNNN), a Germany-based company specializing in in vitro diagnostics (IVD), has captured the attention of the healthcare sector with its rapid growth and broad..

Zhengye Biotechnology Holding L (ZYBT) Stock Analysis: Navigating a Challenging Landscape in the Veterinary Vaccine Market

Zhengye Biotechnology Holding Limited (ZYBT), operating in the specialized sector of veterinary vaccines within the healthcare industry, presents a complex picture for investors as the company..

TotalEnergies SE (TTE) Stock Analysis: Exploring a 7.43% Potential Upside in the Energy Sector

TotalEnergies SE (TTE), a prominent player in the energy sector, has been garnering attention from investors, not least because of its robust position within the integrated..

Olema Pharmaceuticals, Inc. (OLMA) Stock Analysis: A Biotech with 29.8% Upside Potential

Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) is making waves in the biotechnology sector, and for good reason. As a clinical-stage biopharmaceutical company specializing in innovative therapies for..

Mereo BioPharma Group plc (MREO): Analyst Ratings Signal a Stunning 287% Potential Upside

Mereo BioPharma Group plc (NASDAQ: MREO), a London-based biopharmaceutical company, has captured the attention of investors with its robust pipeline of therapeutic candidates and a remarkable..

Evolent Health, Inc (EVH) Investor Outlook: Exploring a Potential 158% Upside

Evolent Health, Inc. (NASDAQ: EVH) is a prominent player in the healthcare sector, specifically within the health information services industry. Headquartered in Arlington, Virginia, Evolent Health..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Exploring a 47% Potential Upside

For investors seeking opportunities in the healthcare sector, U.S. Physical Therapy, Inc. (NYSE: USPH) presents a compelling proposition. With a market capitalization of $1.09 billion, this..

Wave Life Sciences Ltd. (WVE) Stock Analysis: Exploring a 165% Potential Upside in Biotech Innovation

Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage biotechnology firm based in Singapore, has been garnering considerable attention from investors due to its innovative approach to..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: Navigating Growth with a 16.7% Potential Upside

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH), a key player in the U.S. medical care facilities industry, is capturing investor attention with its robust growth prospects and..

Teladoc Health, Inc. (TDOC) Investor Outlook: Exploring a Potential 27.68% Upside

Teladoc Health, Inc. (NASDAQ: TDOC) stands at a pivotal point in the healthcare sector’s evolution, offering a unique blend of virtual healthcare services designed to meet..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds